Direct Rx recalls Lidocaine Ointment USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug
- Products
-
- Lidocaine Ointment USP
- Company
- Direct Rx
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 493 jars
- About this recall
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50